# Commission Decision of 14 August 2007 concerning the non-inclusion in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market of certain substances to be examined under the 10-year work programme referred to in Article 16(2) thereof (notified under document number C(2007) 3846) (Text with EEA relevance) (2007/565/EC)

EU Decision 2007/565 · adopted 14 August 2007

Commission Decision of 14 August 2007 concerning the non-inclusion in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market of certain substances to be examined under the 10-year work programme referred to in Article 16(2) thereof (notified under document number C(2007) 3846) (Text with EEA relevance) (2007/565/EC)

PDFs: Printed copy https://openlegislation.uk/eu-decision-2007-565/pdf/eudn_20070565_adopted_en.pdf

## Introductory text

Commission Decision
of 14 August 2007
concerning the non-inclusion in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market of certain substances to be examined under the 10-year work programme referred to in Article 16(2) thereof
(notified under document number C(2007) 3846)
(Text with EEA relevance)
(2007/565/EC)
THE COMMISSION OF THE EUROPEAN COMMUNITIES,
Having regard to the Treaty establishing the European Community,
Having regard to Directive 98/8/EC of the European Parliament and of the Council of 16 February 1998 concerning the placing of biocidal products on the market, and in particular the second subparagraph of Article 16(2) thereof,
Whereas:
(1)
Commission Regulation (EC) No 2032/2003 of 4 November 2003 on the second phase of the 10-year work programme referred to in Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market and amending Regulation (EC) No 1896/2000 establishes a list of active substances to be assessed, with a view to their possible inclusion in Annex I, IA or IB to Directive 98/8/EC.
(2)
For a number of substances/product type combinations included on that list either all participants have withdrawn from the review program in accordance with Article 8(2) of Regulation (EC) No 2032/2003 or no complete dossier as referred to in Article 9(5) of that Regulation was received within the time period specified in Annexes V and VIII thereof by the Rapporteur Member State designated for the evaluation.
(3)
Consequently, pursuant to Article 8(3) and (4) and Article 9 (5) of Regulation (EC) No 2032/2003, the Commission informed the Member States accordingly. That information was also made public by electronic means on 14 June 2006.
(4)
Within three months of the electronic publication of that information, no company or Member State indicated an interest in taking over the role of participant for the substances and product-types concerned.
(5)
The substances and product-types concerned should therefore be removed from the Review Programme and not be included in Annexes I, IA or IB to Directive 98/8/EC.
(6)
The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on Biocidal Products,
HAS ADOPTED THIS DECISION:

## 1 

The substances and the product-types indicated in the Annex to this Decision shall not be included in Annexes I, IA or IB to Directive 98/8/EC.

## 2 

For the purposes of the third subparagraph of Article 4(2) of Regulation (EC) No 2032/2003, this Decision shall apply from the day following its publication in the Official Journal of the European Union.

## 3 

This Decision is addressed to the Member States.

## Signature

Done at Brussels, 14 August 2007.
For the Commission
Stavros Dimas
Member of the Commission

## 

Substances and product-types not to be included in Annexes I, IA and IB to Directive 98/8/EC
Name
EC No
CAS No
Product-type
Bis[1-cyclohexyl-1,2-di(hydroxy-.kappa.O)diazeniumato(2-)]-copper
312600-89-8
21
Formic acid
200-579-1
64-18-6
18
Propan-2-ol
200-661-7
67-63-0
18
L-(+)-lactic acid
201-196-2
79-33-4
1
L-(+)-lactic acid
201-196-2
79-33-4
13
Anthraquinone
201-549-0
84-65-1
19
1,4-dichlorobenzene
203-400-5
106-46-7
18
1,4-dichlorobenzene
203-400-5
106-46-7
19
N-(2-ethylhexyl)-8,9,10-trinorborn-5-ene-2,3-dicarboximide
204-029-1
113-48-4
18
Benzyl benzoate
204-402-9
120-51-4
19
Malathion
204-497-7
121-75-5
18
Octanoic acid
204-677-5
124-07-2
19
Captan
205-087-0
133-06-2
21
N-(trichloromethylthio)phthalimide/Folpet
205-088-6
133-07-3
21
Ziram
205-288-3
137-30-4
19
Ziram
205-288-3
137-30-4
21
Thiabendazole
205-725-8
148-79-8
21
Diuron
206-354-4
330-54-1
21
(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl-(1RS,3RS;1RS,3SR)-2,2-dimethyl-3-(2-methylprop-1-enyl)-cyclopropanecarboxylate (all isomers; ratio: 1:1:1:1:1:1:1:1)/Allethrin
209-542-4
584-79-2
18
Zinc sulphide
215-251-3
1314-98-3
18
Zinc sulphide
215-251-3
1314-98-3
21
Disodium tetraborate, anhydrous
215-540-4
1330-43-4
18
Naphthenic acids, copper salts
215-657-0
1338-02-9
8
Chlorothalonil
217-588-1
1897-45-6
21
Fluometuron
218-500-4
2164-17-2
21
Chlorpyrifos
220-864-4
2921-88-2
18
Chlorpyrifos-methyl
227-011-5
5598-13-0
18
(R)-p-mentha-1,8-diene
227-813-5
5989-27-5
18
(R)-p-mentha-1,8-diene
227-813-5
5989-27-5
19
Prometryn
230-711-3
7287-19-6
21
Silicon dioxide — amorphous
231-545-4
7631-86-9
16
Silicon dioxide — amorphous
231-545-4
7631-86-9
19
Bone oil/Animal oil
232-294-3
8001-85-2
19
Rape oil
232-299-0
8002-13-9
18
Lignin
232-682-2
9005-53-2
19
Lignin
232-682-2
9005-53-2
21
Oxine-copper
233-841-9
10380-28-6
8
Disodium octaborate tetrahydrate
234-541-0
12280-03-4
18
Dodecylguanidine monohydrochloride
237-030-0
13590-97-1
16
Dodecylguanidine monohydrochloride
237-030-0
13590-97-1
21
Phoxim
238-887-3
14816-18-3
18
Chlorotoluron
239-592-2
15545-48-9
21
Methomyl
240-815-0
16752-77-5
18
Dimethyloctadecyl[3-(trimethoxysilyl)propyl]ammonium chloride
248-595-8
27668-52-6
21
(S)-3-allyl-2-methyl-4-oxocyclopent-2-enyl(1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)-cyclopropanecarboxylate (only 1R trans, 1S isomer)/S-Bioallethrin
249-013-5
28434-00-6
18
Bioresmethrin
249-01-40
28434-01-7
18
Trans-isopropyl-3-[[(ethylamino)methoxyphosphinothioyl]oxy]crotonate
250-517-2
31218-83-4
18
Amitraz
251-375-4
33089-61-1
18
3-(4-isopropylphenyl)-1,1-dimethylurea/Isoproturon
251-835-4
34123-59-6
18
3-(4-isopropylphenyl)-1,1-dimethylurea/Isoproturon
251-835-4
34123-59-6
21
m-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate/Permethrin
258-067-9
52645-53-1
19
3-iodo-2-propynyl butylcarbamate
259-627-5
55406-53-6
18
Cis-4-[3-(p-tert-butylphenyl)-2-methylpropyl]-2,6-dimethylmorpholine/Fenpropimorph
266-719-9
67564-91-4
21
Quaternary ammonium compounds, benzyl-C12-18-alkyldimethyl, chlorides
269-919-4
68391-01-5
16
Quaternary ammonium compounds, benzyl-C12-18-alkyldimethyl, chlorides
269-919-4
68391-01-5
18
Quaternary ammonium compounds, benzyl-C12-18-alkyldimethyl, chlorides
269-919-4
68391-01-5
19
Quaternary ammonium compounds, benzyl-C12-18-alkyldimethyl, chlorides
269-919-4
68391-01-5
21
Quaternary ammonium compounds, di-C8-10-alkyldimethyl, chlorides
270-331-5
68424-95-3
16
Melaleuca alternifolia, ext./Australian Tea Tree Oil
285-377-1
85085-48-9
19
2,4,8,10-tetra(tert-butyl)-6-hydroxy-12H-dibenzo[d,g][1,3,2]dioxaphosphocin 6-oxide, sodium salt
286-344-4
85209-91-2
1
Quaternary ammonium compounds, benzyl-C12-14-alkyldimethyl, chlorides
287-089-1
85409-22-9
16
Quaternary ammonium compounds, benzyl-C12-14-alkyldimethyl, chlorides
287-089-1
85409-22-9
18
Quaternary ammonium compounds, benzyl-C12-14-alkyldimethyl, chlorides
287-089-1
85409-22-9
19
Quaternary ammonium compounds, benzyl-C12-14-alkyldimethyl, chlorides
287-089-1
85409-22-9
21
Quaternary ammonium compounds, C12-14-alkyl[(ethylphenyl)methyl]dimethyl, chlorides
287-090-7
85409-23-0
16
Quaternary ammonium compounds, C12-14-alkyl[(ethylphenyl)methyl]dimethyl, chlorides
287-090-7
85409-23-0
18
Quaternary ammonium compounds, C12-14-alkyl[(ethylphenyl)methyl]dimethyl, chlorides
287-090-7
85409-23-0
19
Quaternary ammonium compounds, C12-14-alkyl[(ethylphenyl)methyl]dimethyl, chlorides
287-090-7
85409-23-0
21
.alpha.-cyano-4-fluoro-3-phenoxybenzyl [1.alpha.(S*),3.alpha.]-(±)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate
289-244-9
86560-93-2
18
Chrysanthemum cinerariaefolium, ext.
289-699-3
89997-63-7
19
Juniper, Juniperus mexicana, ext.
294-461-7
91722-61-1
19
Lavender, Lavandula hybrida, ext./Lavandin oil
294-470-6
91722-69-9
18
3-benzo(b)thien-2-yl-5,6-dihydro-1,4,2-oxathiazine,4-oxide
431-030-6
163269-30-5
21
Chloromethyl n-octyl disulfide
432-680-3
180128-56-7
21
Potassium salts of fatty acids (C15-21)
Mixture
—
18
(E)-2-Octadecenal
Not yet allocated
51534-37-3
19
(E,Z)-2,13-Octadecadienal
Not yet allocated
99577-57-8
19
S-Hydroprene/Ethyl (S-(E,E))-3,7,11-trimethyldodeca-2,4-dienoate
Plant protection product
65733-18-8
18
4-Bromo-2-(4-chlorophenyl)-1-(ethoxymethyl)-5-(trifluoromethyl)-1H-pyrrole-3-carbonitrile/Chlorfenapyr
Plant protection product
122453-73-0
21

---
Source: https://www.legislation.gov.uk/eudn/2007/565 (the official version)
Page: https://openlegislation.uk/eu-decision-2007-565
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.